Joan Greer

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare workers in a low prevalence region

G. Bearman, Alison J. Montpetit, R. Pryor, 2020, Infection Control & Hospital Epidemiology.

COVID-19 seroprevalence among healthcare workers in a low prevalence region.

G. Bearman, Alison J. Montpetit, R. Pryor, 2020, Infection control and hospital epidemiology.

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial

L. Korbee, B. Trapnell, B. V. Van Tassell, 2021, The Lancet Rheumatology.

Clinical trial enrollment at a rural satellite hospital during COVID-19 pandemic

B. V. Van Tassell, A. Abbate, Heather Kemp, 2021, Journal of Clinical and Translational Science.